閉場中RVOL 0.8xDV $51,64120日平均DV $64,479?
Earnings 2026-10-0952W high -72.5%52W low +812.1%Market cap $6MAvg volume 47K
Company Overview
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q3 | -0.80 | $20,942 | -$1M |
| 2025 Q2 | -0.61 | $0 | -$1M |
| 2025 Q1 | 1.04 | $0 | -$1M |
| 2025 Q4 | -60.88 | $0 | -$2M |
| 2025 Q3 | 0.09 | $0 | -$1M |
| 2024 Q2 | -3.20 | $0 | -$3M |
| 2024 Q1 |
